Get the Stockscreener App
168.45
0.08%
0.13
After Hours:
168.01
-0.44
-0.26%
Natera Inc stock is traded at $168.45, with a volume of 942.50K.
It is up +0.08% in the last 24 hours and up +43.15% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$168.32
Open:
$170.88
24h Volume:
942.50K
Relative Volume:
0.79
Market Cap:
$20.61B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-34.95
EPS:
-4.82
Net Cash Flow:
$-43.68M
1W Performance:
+0.34%
1M Performance:
+43.15%
6M Performance:
+53.82%
1Y Performance:
+206.05%
1-Day Range:
$166.58
$170.94
1-Week Range:
$161.25
$171.95
52-Week Range:
$53.88
$171.95
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
168.45 | 20.61B | 1.53B | -214.69M | -43.68M | -4.82 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
KAS Team Wins $292.5 Million In Jury Trial of Guardant Health v. Natera - Morningstar
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients - Business Wire
Natera, Inc. (NASDAQ:NTRA) Shares Acquired by Cerity Partners LLC - MarketBeat
Penserra Capital Management LLC Has $1.40 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Charles Schwab Investment Management Inc. Cuts Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Jury awards Guardant nearly $293M in lawsuit against Natera - LabPulse
Guardant Wins False Advertising Lawsuit Against Natera - MD+DI
Guardant awarded $293M in false advertising case against fellow cancer test maker Natera - FiercePharma
Guardant awarded $292M in false advertising suit against Natera - Fierce Biotech
Loomis Sayles & Co. L P Has $33.91 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Harvest Fund Management Co. Ltd Grows Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera faces setback in false advertising lawsuit By Investing.com - Investing.com South Africa
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Malaysian Reserve
Natera to Present Breakthrough Signatera Cancer Trial Data at SABCS | NTRA Stock News - StockTitan
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium - Business Wire
Jury Awards Guardant Health $292.5M in False-Advertising Lawsuit Against Natera - MarketWatch
Guardant says jury unanimously found in favor of company in Natera suit - TipRanks
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims - MSN
Guardant Health Wins Historic $292.5M False Advertising Verdict Against Natera | NTRA Stock News - StockTitan
Natera faces setback in false advertising lawsuit - Investing.com
Natera Plans Appeal After Guardant Health Lawsuit Verdict, Defends Signatera Test Leadership | NTRA Stock News - StockTitan
BREAKING: Jury Finds Natera Owes Guardant $292.5M In False Ad Suit - Law360
Natera Co-Founder Wins 2024 R&D Leader of Year for Breakthrough Genetic Testing | NTRA Stock News - StockTitan
New Stock PurchasedNatera Inc $NTRA - substack.com
Long Term Trading Analysis for (NTRA) - Stock Traders Daily
Alpha DNA Investment Management LLC Invests $505,000 in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Trade Alert: Independent Director Of Natera Gail Marcus Has Sold Stock - Simply Wall St
Natixis Advisors LLC Raises Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 3.1% After Insider Selling - MarketBeat
Natera director Marcus Gail boxer sells $1.55 million in stock - Investing.com India
Natera's Conduct 'Despicable,' Guardant Says As Trial Wraps - Law360
Stanley Druckenmiller Portfolio: 7 Top Stocks in 2024 | Investing - U.S News & World Report Money
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Eagle Asset Management Inc. - MarketBeat
Massachusetts Financial Services Co. MA Purchases 85,236 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Invests $9.16 Million in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
United States Non-Invasive Prenatal Testing Market Report - GlobeNewswire
Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM - BioSpace
Insider Sell: Gail Marcus Sells 9,682 Shares of Natera Inc (NTRA) - GuruFocus.com
Stanley Druckenmiller makes big bet on high-tech healthcare - TheStreet
Natera director Marcus Gail boxer sells $1.55 million in stock By Investing.com - Investing.com Canada
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Brown Capital Management LLC - MarketBeat
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings - The Motley Fool
Natera, Inc. (NASDAQ:NTRA) Shares Bought by Jennison Associates LLC - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Stake Lowered by Segall Bryant & Hamill LLC - MarketBeat
Natera price target raised to $165 from $150 at Canaccord - MSN
Natera stock soars to all-time high, reaching $167.81 By Investing.com - Investing.com South Africa
Natera stock soars to all-time high, reaching $167.81 - Investing.com India
3 Under-the-Radar Healthcare Companies - MSN
Meeder Asset Management Inc. Buys 3,184 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Sold by LMR Partners LLP - MarketBeat
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):